Science and Research

Novel therapeutic approaches to tackling oncology, type 2 diabetes and obesity.

(OSI) Pharmaceuticals has developed an extensive, fully integrated drug discovery organization generating a pipeline of high-quality drug candidates to move into clinical development. This research operation is built upon the Company’s strengths, including high-throughput screening, chemical libraries, medicinal and combinatorial chemistry, and automated drug profiling technology platforms.




For more information on OSI Oncology compounds for academic research,
click here


OSI Oncology

At OSI, we strive to be at the forefront of the war against cancer by arming patients with an arsenal of tools to help them manage their disease and live productive lives. Our success is based on our ability to discover and develop molecular targeted therapies that enable a sea change in how cancer patients are treated.

Learn more

EMT

Our research organization is focused on the discovery of novel small molecule compounds targeted against the underlying molecular mechanisms of the pathogenesis of cancer. Our strategy is to develop mechanism-based approaches to drug discovery directed at the processes underlying the role of the Epithelial Mesenchymal Transition (EMT) in the development of cancer.

Learn more